EsoCap AG announced presentation of new data, with smart application technology in the upper gastrointestinal tract demonstrating that long-lasting topical drug therapy within the esophagus is achievable for the first time. The University of Greifswald, Germany, conducted an imaging study in twelve healthy volunteers, with the objective of evaluating esophageal disposition of thin films. The […]

Read more

EsoCap AG organized a multidisciplinary scientific advisory board meeting in Zurich with thirteen international experts on June 27, 2019. As an introduction, Prof. Werner Weitschies, Center for Drug Absorption and Transport at the University of Greifswald, gave a presentation on the Esophageal Wafer Study conducted in healthy volunteers by the University of Greifswald. The excellent […]

Read more

EsoCap AG announced that a capital increase has been authorized by the Extraordinary General Assembly, held on April 11, 2019, followed by successful completion of a private placement financing. The proceeds of the private placement will be used to complete a clinical proof-of-concept trial in eosinophilic esophagitis (EoE). “We are delighted to have secured the […]

Read more

Basel, Switzerland, February 6, 2019 EsoCap AG and LTS Lohmann Therapy-Systeme AG announced the start of cooperation on industrial development of a unique drug delivery technology for diseases of the upper gastrointestinal tract. This collaboration leverages the collective expertise of a strong partner in the thin film industry with a highly innovative application technology. “We […]

Read more

Basel, Switzerland, July 13th, 2018 EsoCap AG announced that it has successfully completed a private placement financing round on July 13th, 2018. The proceeds of the capital increase will be used toward the completion of the technical development of EsoCap’s unique drug delivery technology and the initiation of a clinical proof-of-concept trial in eosinophilic esophagitis […]

Read more

EsoCap AG organized a scientific advisory board meeting with eight international experts in Eosinophilic Esophagitis (EoE) in Zürich on June 14th, 2018.

Prof. Dr. Werner Weitschies, Head of the Center of Drug Absorption and Transport at the University of Greifswald gave a keynote presentation on EsoCap’s unique drug delivery platform.

Read more

EsoCap announced that Sven Hoffmann and Isabelle Racamier have been appointed to the Company’s Board of Directors. “I am delighted to welcome Isabelle and Sven to the EsoCap Board. Both of them are highly talented executives bringing deep industry experience and a proven track record of building value” said Dr. Werner Tschollar, Chairman of the […]

Read more